Coronavirus | ICMR, Bharat Biotech tie up for Indian COVID-19 vaccine
Virus strain from NIV Pune transferred. The Indian Council for Medical Research (ICMR) on Saturday announced a research collaboration with…
Virus strain from NIV Pune transferred. The Indian Council for Medical Research (ICMR) on Saturday announced a research collaboration with…
While the government and scientists all over the world are trying to develop an effective vaccine against the deadly coronavirus,…
NEW DELHI: Prime Minister Narendra Modi on Tuesday reviewed the progress made by India in the development of a vaccine…
WASHINGTON: President Donald Trump on Sunday said the United States will have a coronavirus vaccine by the end of this…
The story so far: On April 23, Oxford University initiated a phase-1 human clinical trial of its vaccine — ChAdOx1…
Fewer than half of Americans plan to go to sports events, concerts, movies and amusement parks when they reopen to…
LONDON: A Kolkata woman is playing a crucial role in the Oxford University team trying to develop the Covid-19 vaccine…
(Reuters) - In the race to develop a vaccine to end the COVID-19 pandemic, governments, charities and Big Pharma firms…
City-based Serum Institute of India has said that it expects the vaccine for coronavirus (COVID-19) developed by the University of…
Updated April 23, 2020 19:28:11 There's another potential coronavirus vaccine taking that next step to human trials this week.This time…
SUIFENHE, China (Reuters) - China has approved early-stage human tests of two experimental vaccines to combat the new coronavirus as…
New South Wales Premier Gladys Berejiklian has warned that social distancing restrictions will be in place in her state "until…
Doctors and scientists in India have expressed caution on a study, which argues that countries that have deployed the BCG-tuberculosis…
The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency, has commenced the first stage of testing potential…
FILE PHOTO: The company logo for Johnson & Johnson is displayed on a screen to celebrate the 75th anniversary of…
Even if everything goes to plan, it will take at least 12-18 months for a novel coronavirus (SARS-CoV-2) vaccine to…
The story so far: A Phase-1 clinical trial on 45 healthy volunteers between the ages of 18 and 55 years…
(Reuters) - The European Medicines Agency (EMA) said it was taking steps to speed up the development of vaccines and…